A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089

References

• Langer CJ. Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges. Oncology/Hematology 2012; 83:130–44.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62(1):10-29; PMID:22237781
   PubMed Web of Science ®Google Scholar
• Saintigny P, Burger JA, Recent advances in non-small cell lung cancer biology and clinical management. Discov Med 2012; 13(71):287-97; PMID:22541616
   PubMed Web of Science ®Google Scholar
• Wintner LM, Giesinger JM, Zabernigg A, Sztankay M, Meraner V, Pall G, Hilbe W, Holzner B. Quality of life during chemotherapy in lung cancer patients: results across different treatment lines. Br J Cancer 2013; 109(9):2301-8; PMID:24091620; http://dx.doi.org/10.1038/bjc.2013.585
   PubMed Web of Science ®Google Scholar
• Cai S, Shi A, Yu R, Zhu G. Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2014; 9:17; PMID:24410971; http://dx.doi.org/10.1186/1748-717X-9-17
   PubMed Web of Science ®Google Scholar
• Bayman N, Blackhall F, McCloskey P, Taylor P, Faivre-Finn C. How can we optimize concurrent cheoradiotherapy for inoperable stage III non-small cell lung cancer? Lung Cancer 2014; n83(2): 117-25; PMID:24373738; http://dx.doi.org/10.1016/j.lungcan.2013.11.017
   PubMed Web of Science ®Google Scholar
• Hamamoto Y, Kataoka M, Nogami N, Kozuki T, Kato Y, Shinohara S, and Shinkai T. Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemotherapy. Jpn J Radiol 2012; 30(3):249-54; PMID:22311092; http://dx.doi.org/10.1007/s11604-011-0040-9
   PubMed Web of Science ®Google Scholar
• Sundaram S, Gewirtz DA. The vitamin D3 analog EB 1089 enhances the response of human breast tumor cells to radiation. Radiat Res 1999; 152(5):479-86; PMID:10521924
   PubMed Web of Science ®Google Scholar
• Gewirtz DA, Gupta MS, Sundaram S. Vitamin D3 and vitamin D3 analogues as an adjunct to cancer chemo-therapy and radiotherapy. Curr Med Chem Anticancer Agents 2002; 2(6):683-90; PMID:12678720; http://dx.doi.org/10.2174/1568011023353697
   PubMedGoogle Scholar
• Sundaram S, Sea A, Feldman S, Strawbridge R, Hoopes PJ, Demidenko E, Binderup L, Gewirtz DA. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 2003; 9(6):2350-6; PMID:12796405
   PubMed Web of Science ®Google Scholar
• Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am 2012; 38(1):161-78; PMID:22525850; http://dx.doi.org/10.1016/j.rdc.2012.03.014
   PubMed Web of Science ®Google Scholar
• Ramnath N, Kim S, Christenden PJ. Vitamin D and lung cancer. Expert Rev Respir Med 2011; 5(3):305-9; PMID:21702651; http://dx.doi.org/10.1586/ers.11.31
   PubMed Web of Science ®Google Scholar
• Trump DL, Muindi J, Faikh M, Yu WD, Johnson CS. Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res 2006; 26(4A):2551-6; PMID:16886663
   PubMed Web of Science ®Google Scholar
• Srinivasan M, Parwani VA, Hershberger AP, Lenzner ED, Weissfeld LJ. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol 2011; 123(1-2):30-6; PMID:20955794
   PubMed Web of Science ®Google Scholar
• Kim HS, Chen G, King NA, Jeon KC, Christensen JP, Zhao L, Simpson RU, Thomas DG, Giordano TJ, Brenner DE, et al. Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung cancer 2012; 77(2):265-71; PMID:22564539; http://dx.doi.org/10.1016/j.lungcan.2012.04.010
   PubMed Web of Science ®Google Scholar
• Menezes RJ, Cheney RT, Husain A, Tretiakova M, Loewen G, Johnson CS, Jayaprakash V, Moysich KB, Salgia R, Reid ME. Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue. Cancer Epidemiol Biomarkers Prev 2008; 17(5):1104-10; PMID:18483332; http://dx.doi.org/10.1158/1055-9965.EPI-07-2713
   PubMed Web of Science ®Google Scholar
• Zhou W, Heist SR, Liu G, Asomaning K, Neuberg SD, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L et al. Circulating 25-Hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007; 25(5):479-85; PMID:17290055; http://dx.doi.org/10.1200/JCO.2006.07.5358
   PubMed Web of Science ®Google Scholar
• Bristol ML, Di X, Beckman MJ, Wilson EN, Henderson SC, Maiti A, Fan Z, Gewirtz DA. Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprtective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D3. Autophagy 2012; 8(5):739-53; PMID:22498493; http://dx.doi.org/10.4161/auto.19313
   PubMed Web of Science ®Google Scholar
• Wilson EN, Bristol ML, Di X, Maltese WA, Koterba K, Beckman MJ, Gewirtz DA. A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm Cancer 2011; 2(5):272-85; PMID:21887591; http://dx.doi.org/10.1007/s12672-011-0081-7
   PubMedGoogle Scholar
• Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)- mediated actions of 1α, 25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 543-59; PMID:21872797
   PubMed Web of Science ®Google Scholar
• Demasters G, Di X, Newsham I, Shiu R, Gewirtz DA. Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 2006; 5(11):2786-97; PMID:17121925
   PubMed Web of Science ®Google Scholar
• Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. J Natl Cancer inst 2001; 93(10):745-53; PMID:11353784
   PubMed Web of Science ®Google Scholar
• Jones KR, Elmore LW, Jackson-Cook C, Demasters G, Povirk LF, Holt SE, Gewirtz DA. p53-dependent accelerated senescence induced by ionizing radiation in breast tumor cells. Int J Radiat Biol 2005; 81(6):1686-700; http://dx.doi.org/10.1080/09553000500168549
   Web of Science ®Google Scholar
• Gewirtz DA, Holt SE, Elmore LW. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 2008; 76(8):947-57; PMID:18657518; http://dx.doi.org/10.1016/j.bcp.2008.06.024
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8(4):445-544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
   PubMed Web of Science ®Google Scholar
• Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Marino G, Kepp O, Michaud M, Perfettini JL, et al. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signaling. Cell Death Differ 2014; 21(1):92-9; PMID:24037090; http://dx.doi.org/10.1038/cdd.2013.124
   PubMed Web of Science ®Google Scholar
• Lai SL, Pernq RP, Hwang J. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells. J Biomed Sci 2000; 7(1):64-70; PMID:10644891; http://dx.doi.org/10.1007/BF02255920
   PubMed Web of Science ®Google Scholar
• Luo ZG, Tang H, Li B, Zhu Z, Ni CR, Zhu MH. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer. Oncol Rep 2011; 25(4):1073-81; PMID:21286670
   PubMed Web of Science ®Google Scholar
• You L, Yang CT, Jablons DM. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients. Cancer Res 2000; 60(4):1009-13; PMID:10706117
   PubMed Web of Science ®Google Scholar
• Zhang F, Wang W, Tsuji Y, Torti SV, Torti FM. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 2008; 283(49):33911-8; PMID:18819919; http://dx.doi.org/10.1074/jbc.M806432200
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13(4):251-62; PMID:22436748; http://dx.doi.org/10.1038/nrm3311
   PubMed Web of Science ®Google Scholar
• Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012; 52:381-400; PMID:22017684; http://dx.doi.org/10.1146/annurev-pharmtox-010611-134537
   PubMed Web of Science ®Google Scholar
• Singh K, Matsuyama S, Drazba JA, Almasan A. Autophagy-dependent senescence in response to DNA damage and chronic apoptosis stress. Autophagy 2012; 8(2):236-51; PMID:22240589; http://dx.doi.org/10.4161/auto.8.2.18600
   PubMed Web of Science ®Google Scholar
• Van Kaick G, Delorme S. Therapy induced effects in normal tissue. Radiologe 2008; 48(9):871-80; PMID:18709346; http://dx.doi.org/10.1007/s00117-008-1729-3
   PubMed Web of Science ®Google Scholar
• Yang WL, Perillo W, Liou D, Marambaud P, Wang P. AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells. J Surg Oncol 2012; 106(6):680-8; PMID:22674626; http://dx.doi.org/10.1002/jso.23184
   PubMed Web of Science ®Google Scholar
• Cheng G, Kong D, Hou X, Liang B, He M, Liang N, Ma S, Liu X. The tumor suppressor, p53, contributes to radiosensitivity of lung cancer cells by regulating autophagy and apoptosis. Cancer Biother Radiopharm 2013; 28(2):153-9; PMID:23268708; http://dx.doi.org/10.1089/cbr.2012.1297
   PubMed Web of Science ®Google Scholar
• Lorin S, Hamaï A, Mehrpour M, and Codogno P. Autophagy regulation and its role in cancer. Semin Cancer Biol 2013; 28(2):152-9; PMID:23811268; http://dx.doi.org/10.1016/j.semcancer.2013.06.007
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang H, Levine AJ, Jin S. The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 2005; 102(23):8204-9.
   PubMed Web of Science ®Google Scholar
• Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ. The regulation of AMPK beta1, TSC2 and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007; 67(7):3043-53; PMID:17409411; http://dx.doi.org/10.1158/0008-5472.CAN-06-4149
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. ULK-Atg 13-FIP200 complexes mediate mTOR signaling to autophagy machinery. Mol Biol Cell 2009; 20(7):1992-2003; PMID:19225151; http://dx.doi.org/10.1091/mbc.E08-12-1249
   PubMed Web of Science ®Google Scholar
• Gao W, Shen Z, Shang L, and Wang X. Up-regulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ 2011; 18(10):1598-607; PMID:21475306; http://dx.doi.org/10.1038/cdd.2011.33
   PubMed Web of Science ®Google Scholar
• Jeong Y, Xie Y, Lee W, Bookout AL, Girard L, Raso G, Behrens C, Wistuba II, Gadzar AF, Minna JD et al. Research Resource: Diagnostic and Therapeutic potential of nuclear receptor expression in lung cancer. Mol Endocrinol 2012; 26(8):1443-1454; PMID:22700587; http://dx.doi.org/10.1210/me.2011-1382
   PubMed Web of Science ®Google Scholar
• Yang YF Wu CC, Chen WP, Chen YL, Su MJ. Prazosin induces p53-mediated autophagic cell death in H9C2 cells. Naunyn Schmiedebergs Arch Pharmacol 2011; 384(2):209-16; PMID:21614555; http://dx.doi.org/10.1007/s00210-011-0657-3
   PubMed Web of Science ®Google Scholar
• Polar MK, Gennings C, Park M, Gupta MS, Gewirtz DA. Effect of vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal fibroblasts. Cancer Chemother Pharmacol 2003; 51(5):415-21; PMID:12690516
   PubMed Web of Science ®Google Scholar
• Liu Y, Shoji-Kawata S, Sumpter RM, Wei Y, Ginet V, Zhang L, Posner B, Tran KA, Green DR, Xavier RJ et al. Autosis is a Na+, K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Natl Acad Sci U S A 2013; 110(51): 20364-71.
   PubMed Web of Science ®Google Scholar
• Overmeyer JH, Maltese WA. Death pathways triggered by activated Ras in cancer cells. Front Biosci 2011; 16:1693-713; PMID:21196257; http://dx.doi.org/10.2741/3814
   PubMed Web of Science ®Google Scholar
• Fulda S. The mechanism of necroptosis in normal and cancer cells. Cancer Biol Ther 2013; 14(11):999-1004; PMID:24025353; http://dx.doi.org/10.4161/cbt.26428
   PubMed Web of Science ®Google Scholar
• Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AE, Shaw JW et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs. P16 bypass, telomerase are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66(4):2116-28; PMID:16489012
   PubMed Web of Science ®Google Scholar
• Maecker HL, Koumenis C, Giaccia AJ. P53 promotes selection for Fas-mediated apoptotic resistance. Cancer Res 2000; 60(16):4638-44; PMID:10969818
   PubMed Web of Science ®Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92(20):9363-7; PMID:7568133
   PubMed Web of Science ®Google Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated β-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4(12):1798-806; PMID:20010931; http://dx.doi.org/10.1038/nprot.2009.191
   PubMed Web of Science ®Google Scholar
• Menon VR, Peterson EJ, Valerie K, Farrell NP, Povirk LF. Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest. Biochem Pharmacol 2013; 86(12): 1708-20; PMID:24161784; http://dx.doi.org/10.1016/j.bcp.2013.10.012
   PubMed Web of Science ®Google Scholar
• Gagou EM, Zuazua-Villar P, Meuth M. Enhanced H2Ax phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Bio Cell 2010; 21(5):739-52; PMID:20053681; http://dx.doi.org/10.1016/10.1091/mbc.E09-07-0618
   PubMed Web of Science ®Google Scholar